TCRX Chart
See on advanced chart >
About
TScan Therapeutics, Inc. was incorporated in Delaware on April 17, 2018. The company is a preclinical-stage biopharmaceutical company focused on developing a robust pipeline of T cell receptor-engineered T cell, or TCR-T, therapies for the treatment of...
Read More
- HighlightA preclinical-stage biopharmaceutical company that developing T cell receptor engineered T cell therapies for the treatment of cancer
- ExchangeNASDAQ
- Listing Date07/16/2021
- Established Date04/17/2018
- Full-time Employees154
- Address830 Winter Street Waltham Massachusetts 02451
- Tel1-857-3999500
- Website
- Fiscal Year End Date12/31
- Security TypeCommon Stock
Industry
Pharmaceuticals